A unique nanoscale drug that can carry a variety of weapons and sneak into cancer cells to break them down from the inside has a new component: a protein that stimulates the immune system to attack HER2-positive breast cancer cells...
Geneticists confirm herbal remedy carcinogen
8/12/2013
In a study that identifies the striking genetic changes caused by a herb compound, scientists have found a direct link between aristolochic acid - used in a traditional herbal remedy - and upper urinary tract cancers...
Celgene has confirmed that Pomalidomide Celgene® - (pomalidomide), a new oral blood cancer therapy, has been granted Marketing Authorisation by the European Medicines Agency and is now available in the UK and Ireland...
Scientists identify biomarker to predict immune response risk after stem cell transplants
8/12/2013
Researchers from Indiana University, the University of Michigan, the Fred Hutchinson Cancer Research Center and the Dana-Farber Cancer Institute have identified and validated a biomarker accessible in blood tests that could be used to predict which stem cell transplant patients are at highest risk for a potentially fatal immune response called graft-versus-host disease...
Occupational cancer now leading cause of compensated work-related deaths in Canada
8/12/2013
Occupational cancer is now the leading cause of compensated work-related deaths in Canada, surpassing those from accidents and injuries, according to new research published today in CMAJ Open...
Ovarian cancer sniffed out by dogs
8/12/2013
Researchers are looking to create a breakthrough method of detecting ovarian cancer - by using dogs to sniff out the disease. A group of researchers collaborated to investigate using canine olfaction and chemical and nanotechnology analysis as a means of detecting early-stage ovarian cancer...
Drug design to target cancer and inflammatory disease aided by chemists
8/12/2013
Chemists at Indiana University Bloomington have produced detailed descriptions of the structure and molecular properties of human folate receptor proteins, a key development for designing new drugs that can target cancer and inflammatory diseases without serious side effects...
Researchers at the Moffitt Cancer Center have identified four inherited genetic variants in non-small cell lung cancer patients that can help predict survival and treatment response. Their findings could help lead to more personalized treatment options and improved outcomes for patients...
Generally, FDA-approved clinical trials progress through three phases: the first shows safety, the second starts to explore effects and the third seeks to prove a drug's superiority over existing treatments...
Ovarian cancer sniffed out by dogs
8/12/2013
Researchers are looking to create a breakthrough method of detecting ovarian cancer - by using dogs to sniff out the disease. A group of researchers collaborated to investigate using canine olfaction and chemical and nanotechnology analysis as a means of detecting early-stage ovarian cancer...